IL96020A - Preparations containing L-monosaccharide sugar that provide volume in the feces and laxity in the intestines of mammals - Google Patents

Preparations containing L-monosaccharide sugar that provide volume in the feces and laxity in the intestines of mammals

Info

Publication number: IL96020A
Authority: IL; Israel
Prior art keywords: glucose; laxative; sugar; subjects; laxation
Prior art date: 1989-10-17

Application number

IL9602090A

Other languages

English (en)

Hebrew (he)

Other versions

IL96020A0 (en

Original Assignee

Hershey Foods Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-17

Filing date

1990-10-16

Publication date

1995-03-30

1990-10-16 Application filed by Hershey Foods Corp filed Critical Hershey Foods Corp

1991-07-18 Publication of IL96020A0 publication Critical patent/IL96020A0/xx

1995-03-30 Publication of IL96020A publication Critical patent/IL96020A/en

Links

239000000203 mixture Substances 0.000 title claims abstract description 24
235000000346 sugar Nutrition 0.000 title claims description 10
241000124008 Mammalia Species 0.000 title description 3
239000008141 laxative Substances 0.000 claims abstract description 37
230000002475 laxative effect Effects 0.000 claims abstract description 34
150000002772 monosaccharides Chemical class 0.000 claims abstract description 6
235000013305 food Nutrition 0.000 claims description 13
LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 8
WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 claims description 7
230000037396 body weight Effects 0.000 claims description 7
LKDRXBCSQODPBY-NSHGFSBMSA-N L-fructose Chemical compound OCC1(O)OC[C@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-NSHGFSBMSA-N 0.000 claims description 5
125000003677 L-glucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@@H](O)[C@@H](O1)CO)* 0.000 claims description 5
WQZGKKKJIJFFOK-QRXFDPRISA-N L-gulose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QRXFDPRISA-N 0.000 claims description 5
239000000829 suppository Substances 0.000 claims description 5
230000001225 therapeutic effect Effects 0.000 claims description 4
230000037406 food intake Effects 0.000 abstract description 23
229940125722 laxative agent Drugs 0.000 abstract description 15
238000009472 formulation Methods 0.000 abstract description 11
210000001072 colon Anatomy 0.000 abstract description 10
230000003204 osmotic effect Effects 0.000 abstract description 10
235000003599 food sweetener Nutrition 0.000 abstract description 9
239000003765 sweetening agent Substances 0.000 abstract description 9
150000001720 carbohydrates Chemical group 0.000 abstract description 7
230000008901 benefit Effects 0.000 abstract description 6
210000000936 intestine Anatomy 0.000 abstract description 4
235000019629 palatability Nutrition 0.000 abstract description 4
239000000126 substance Substances 0.000 abstract 1
WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 description 82
230000000694 effects Effects 0.000 description 28
206010010774 Constipation Diseases 0.000 description 27
239000007789 gas Substances 0.000 description 18
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 18
238000013456 study Methods 0.000 description 18
206010016766 flatulence Diseases 0.000 description 17
239000000047 product Substances 0.000 description 16
239000000243 solution Substances 0.000 description 16
206010012735 Diarrhoea Diseases 0.000 description 15
230000002496 gastric effect Effects 0.000 description 14
229960000511 lactulose Drugs 0.000 description 14
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 14
KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 12
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 10
208000024891 symptom Diseases 0.000 description 9
210000002700 urine Anatomy 0.000 description 9
206010000060 Abdominal distension Diseases 0.000 description 8
KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 8
206010028813 Nausea Diseases 0.000 description 8
239000004359 castor oil Substances 0.000 description 8
235000019438 castor oil Nutrition 0.000 description 8
150000001875 compounds Chemical class 0.000 description 8
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
239000007788 liquid Substances 0.000 description 8
230000008693 nausea Effects 0.000 description 8
229920001223 polyethylene glycol Polymers 0.000 description 8
206010015137 Eructation Diseases 0.000 description 7
208000027687 belching Diseases 0.000 description 7
235000009508 confectionery Nutrition 0.000 description 7
210000003608 fece Anatomy 0.000 description 7
230000004060 metabolic process Effects 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
239000004067 bulking agent Substances 0.000 description 6
235000011389 fruit/vegetable juice Nutrition 0.000 description 6
235000020357 syrup Nutrition 0.000 description 6
239000006188 syrup Substances 0.000 description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
239000009603 Perdiem Substances 0.000 description 5
229960000503 bisacodyl Drugs 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
235000005911 diet Nutrition 0.000 description 5
230000037213 diet Effects 0.000 description 5
239000000835 fiber Substances 0.000 description 5
239000001257 hydrogen Substances 0.000 description 5
229910052739 hydrogen Inorganic materials 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
238000011282 treatment Methods 0.000 description 5
208000004998 Abdominal Pain Diseases 0.000 description 4
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
241000792859 Enema Species 0.000 description 4
241000282412 Homo Species 0.000 description 4
229930195725 Mannitol Natural products 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
239000002269 analeptic agent Substances 0.000 description 4
230000008859 change Effects 0.000 description 4
230000035622 drinking Effects 0.000 description 4
239000008144 emollient laxative Substances 0.000 description 4
239000007920 enema Substances 0.000 description 4
230000029142 excretion Effects 0.000 description 4
229960005336 magnesium citrate Drugs 0.000 description 4
235000002538 magnesium citrate Nutrition 0.000 description 4
239000004337 magnesium citrate Substances 0.000 description 4
239000000594 mannitol Substances 0.000 description 4
235000010355 mannitol Nutrition 0.000 description 4
238000000034 method Methods 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
238000011084 recovery Methods 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000000600 sorbitol Substances 0.000 description 4
239000012085 test solution Substances 0.000 description 4
PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 4
206010013911 Dysgeusia Diseases 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
230000003187 abdominal effect Effects 0.000 description 3
230000005856 abnormality Effects 0.000 description 3
-1 and preferably Chemical compound 0.000 description 3
229910052788 barium Inorganic materials 0.000 description 3
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
208000024330 bloating Diseases 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
230000000112 colonic effect Effects 0.000 description 3
229940105597 colyte Drugs 0.000 description 3
239000013078 crystal Substances 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
229940099198 dulcolax Drugs 0.000 description 3
229940095399 enema Drugs 0.000 description 3
235000015203 fruit juice Nutrition 0.000 description 3
235000003642 hunger Nutrition 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
235000012054 meals Nutrition 0.000 description 3
230000002503 metabolic effect Effects 0.000 description 3
239000002480 mineral oil Substances 0.000 description 3
235000010446 mineral oil Nutrition 0.000 description 3
230000000391 smoking effect Effects 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
238000012360 testing method Methods 0.000 description 3
241000894006 Bacteria Species 0.000 description 2
244000025596 Cassia laevigata Species 0.000 description 2
235000006693 Cassia laevigata Nutrition 0.000 description 2
208000002881 Colic Diseases 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
206010025476 Malabsorption Diseases 0.000 description 2
208000004155 Malabsorption Syndromes Diseases 0.000 description 2
208000004880 Polyuria Diseases 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
230000009471 action Effects 0.000 description 2
GZCGUPFRVQAUEE-VANKVMQKSA-N aldehydo-L-glucose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-VANKVMQKSA-N 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
235000021152 breakfast Nutrition 0.000 description 2
235000014171 carbonated beverage Nutrition 0.000 description 2
239000000799 cathartic agent Substances 0.000 description 2
229940018612 colace Drugs 0.000 description 2
230000004600 colonic motility Effects 0.000 description 2
238000002052 colonoscopy Methods 0.000 description 2
230000013872 defecation Effects 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
239000003814 drug Substances 0.000 description 2
201000006549 dyspepsia Diseases 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000019634 flavors Nutrition 0.000 description 2
239000012530 fluid Substances 0.000 description 2
229940056944 golytely Drugs 0.000 description 2
244000005709 gut microbiome Species 0.000 description 2
208000024798 heartburn Diseases 0.000 description 2
208000002551 irritable bowel syndrome Diseases 0.000 description 2
BJHIKXHVCXFQLS-FUTKDDECSA-N keto-L-fructose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-FUTKDDECSA-N 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
229940042003 metamucil Drugs 0.000 description 2
230000008447 perception Effects 0.000 description 2
230000001766 physiological effect Effects 0.000 description 2
229940124513 senna glycoside Drugs 0.000 description 2
APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
239000008247 solid mixture Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
208000011580 syndromic disease Diseases 0.000 description 2
235000012431 wafers Nutrition 0.000 description 2
MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
206010000087 Abdominal pain upper Diseases 0.000 description 1
241000208140 Acer Species 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
244000131522 Citrus pyriformis Species 0.000 description 1
240000000560 Citrus x paradisi Species 0.000 description 1
208000000271 Encopresis Diseases 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
235000016623 Fragaria vesca Nutrition 0.000 description 1
240000009088 Fragaria x ananassa Species 0.000 description 1
235000011363 Fragaria x ananassa Nutrition 0.000 description 1
206010052105 Gastrointestinal hypomotility Diseases 0.000 description 1
206010017999 Gastrointestinal pain Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010019196 Head injury Diseases 0.000 description 1
208000037147 Hypercalcaemia Diseases 0.000 description 1
208000013038 Hypocalcemia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 description 1
WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000220225 Malus Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
244000134552 Plantago ovata Species 0.000 description 1
235000003421 Plantago ovata Nutrition 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
206010035742 Pneumonitis Diseases 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
244000018633 Prunus armeniaca Species 0.000 description 1
235000009827 Prunus armeniaca Nutrition 0.000 description 1
239000009223 Psyllium Substances 0.000 description 1
235000014443 Pyrus communis Nutrition 0.000 description 1
240000001987 Pyrus communis Species 0.000 description 1
239000004902 Softening Agent Substances 0.000 description 1
208000020339 Spinal injury Diseases 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
244000290333 Vanilla fragrans Species 0.000 description 1
235000009499 Vanilla fragrans Nutrition 0.000 description 1
235000012036 Vanilla tahitensis Nutrition 0.000 description 1
235000009754 Vitis X bourquina Nutrition 0.000 description 1
235000012333 Vitis X labruscana Nutrition 0.000 description 1
240000006365 Vitis vinifera Species 0.000 description 1
235000014787 Vitis vinifera Nutrition 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
GZCGUPFRVQAUEE-JGWLITMVSA-N aldehydo-L-gulose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-JGWLITMVSA-N 0.000 description 1
210000002255 anal canal Anatomy 0.000 description 1
235000015197 apple juice Nutrition 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
235000012970 cakes Nutrition 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
DWKPZOZZBLWFJX-UHFFFAOYSA-L calcium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate Chemical compound [Ca+2].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC DWKPZOZZBLWFJX-UHFFFAOYSA-L 0.000 description 1
235000013736 caramel Nutrition 0.000 description 1
229960001777 castor oil Drugs 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
239000008370 chocolate flavor Substances 0.000 description 1
235000020434 chocolate syrup Nutrition 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000018823 dietary intake Nutrition 0.000 description 1
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000035619 diuresis Effects 0.000 description 1
230000001882 diuretic effect Effects 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
239000008151 electrolyte solution Substances 0.000 description 1
229940021013 electrolyte solution Drugs 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
235000004626 essential fatty acids Nutrition 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
239000002360 explosive Substances 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
235000020375 flavoured syrup Nutrition 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
230000030135 gastric motility Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
235000014080 ginger ale Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
239000008123 high-intensity sweetener Substances 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000000148 hypercalcaemia Effects 0.000 description 1
208000030915 hypercalcemia disease Diseases 0.000 description 1
230000000705 hypocalcaemia Effects 0.000 description 1
230000002989 hypothyroidism Effects 0.000 description 1
208000003532 hypothyroidism Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000003871 intestinal function Effects 0.000 description 1
BJHIKXHVCXFQLS-OTWZMJIISA-N keto-L-sorbose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-OTWZMJIISA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
235000019223 lemon-lime Nutrition 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229940091250 magnesium supplement Drugs 0.000 description 1
229960001855 mannitol Drugs 0.000 description 1
229940041290 mannose Drugs 0.000 description 1
238000002483 medication Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000003767 neural control Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
208000018360 neuromuscular disease Diseases 0.000 description 1
235000013615 non-nutritive sweetener Nutrition 0.000 description 1
235000021590 normal diet Nutrition 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
201000009868 osmotic diarrhea Diseases 0.000 description 1
208000028719 osmotic diarrheal disease Diseases 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
210000005037 parasympathetic nerve Anatomy 0.000 description 1
210000003903 pelvic floor Anatomy 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000010346 psychosocial stress Effects 0.000 description 1
229940070687 psyllium Drugs 0.000 description 1
235000011962 puddings Nutrition 0.000 description 1
235000015032 reconstituted 100% juice Nutrition 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
229960003656 ricinoleic acid Drugs 0.000 description 1
FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000036186 satiety Effects 0.000 description 1
235000019627 satiety Nutrition 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000000276 sedentary effect Effects 0.000 description 1
208000026775 severe diarrhea Diseases 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000002195 soluble material Substances 0.000 description 1
235000000891 standard diet Nutrition 0.000 description 1
239000008143 stimulant laxative Substances 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
230000004797 therapeutic response Effects 0.000 description 1
238000004448 titration Methods 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000002110 toxicologic effect Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
230000008673 vomiting Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/38—L-sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Saccharide Compounds (AREA)
Outer Garments And Coats (AREA)
Detergent Compositions (AREA)
Chemical Or Physical Treatment Of Fibers (AREA)

IL9602090A 1989-10-17 1990-10-16 Preparations containing L-monosaccharide sugar that provide volume in the feces and laxity in the intestines of mammals IL96020A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/422,694 US5219573A (en)	1989-10-17	1989-10-17	L-sugar laxatives

Publications (2)

Publication Number	Publication Date
IL96020A0 IL96020A0 (en)	1991-07-18
IL96020A true IL96020A (en)	1995-03-30

Family

ID=23675960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9602090A IL96020A (en)	1989-10-17	1990-10-16	Preparations containing L-monosaccharide sugar that provide volume in the feces and laxity in the intestines of mammals

Country Status (13)

Country	Link
US (1)	US5219573A (de)
EP (1)	EP0423771B1 (de)
JP (1)	JP3065648B2 (de)
AT (1)	ATE107860T1 (de)
AU (1)	AU640175B2 (de)
CA (1)	CA2027831C (de)
DE (1)	DE69010301T2 (de)
ES (1)	ES2055270T3 (de)
IE (1)	IE72475B1 (de)
IL (1)	IL96020A (de)
NO (1)	NO904495L (de)
NZ (1)	NZ235698A (de)
ZA (1)	ZA908302B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2711759B2 (ja) *	1990-10-24	1998-02-10	エスエス製薬株式会社	止瀉剤組成物
US5449663A (en) *	1993-06-11	1995-09-12	Bicher; Haim I.	Antineoplastic compositions
US5710183A (en) *	1995-07-14	1998-01-20	Halow; George M.	Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6447763B1 (en) *	1998-06-12	2002-09-10	Ian L. Gordon	Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
US6287719B1 (en)	1998-06-15	2001-09-11	Eveready Battery Company, Inc.	Battery including a non-aqueous multi-cell spiral-wound electrode assembly
RU2163484C1 (ru) *	2000-03-30	2001-02-27	Сибирский медицинский университет	Лекарственное средство и способ коррекции дискинезии желчевыводящей системы и тонкой кишки
WO2002030439A1 (en) *	2000-10-13	2002-04-18	E-Z-Em, Inc.	A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
AUPS088702A0 (en) *	2002-03-04	2002-03-28	Borody, Thomas Julius	Electrolyte purgative
US20040071779A1 (en) *	2002-10-09	2004-04-15	Keiser Dale Arthur	Gelled laxative compositions
US6996500B2 (en) *	2002-10-30	2006-02-07	Hewlett-Packard Development Company, L.P.	Method for communicating diagnostic data
US7049319B2 (en) *	2003-09-23	2006-05-23	Semaan Abboud	Colon cleansing composition and method
US20050255170A1 (en) *	2004-05-13	2005-11-17	Post Sarah S	Large volume enema
US20060247180A1 (en) *	2005-04-29	2006-11-02	Bergey James L	Purgative composition and uses thereof
WO2006118562A1 (en) *	2005-04-29	2006-11-09	Inkine Pharmaceutical Company, Inc.	Purgative composition and uses thereof
KR100749229B1 (ko) *	2005-04-29	2007-08-13	(주)아모레퍼시픽	당 및 당알콜을 함유하는 변비개선용 조성물
US8147445B2 (en)	2005-06-14	2012-04-03	C.B. Fleet Company Inc.	Enema dispenser
US9101160B2 (en)	2005-11-23	2015-08-11	The Coca-Cola Company	Condiments with high-potency sweetener
US8017168B2 (en)	2006-11-02	2011-09-13	The Coca-Cola Company	High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
AU2009268453C1 (en) *	2008-07-09	2016-03-10	The General Hospital Corporation	Dietary purgatives
EP2438077B1 (de) *	2009-06-03	2013-12-04	Aptalis Pharma U.S. Inc.	L-zucker als kolonreinigungsmittel und anwendungen davon
WO2011149471A1 (en) *	2010-05-27	2011-12-01	Clutter Kenton A	Method to prevent/treat post-operative induced constipation
WO2014131024A2 (en) *	2013-02-25	2014-08-28	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
CA2947434A1 (en)	2014-04-29	2015-11-05	Colonaryconcepts Llc	Foods, systems, methods, and kits for providing electrolyte replacement
IT201700028220A1 (it) *	2017-03-14	2018-09-14	Pharmaxima S R L	Sciroppo lassativo
WO2025085413A1 (en) *	2023-10-16	2025-04-24	Mars, Incorporated	Methods of l-sugar production and compositions thereof
AU2024287244B1 (en) *	2024-12-28	2025-08-21	Lai, Meng Hong MR	A device for relieving constipation and its preparation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4262032A (en) *	1976-05-04	1981-04-14	Biospherics Incorporated	Sweetened edible formulations
US4470975A (en) *	1977-10-21	1984-09-11	The Johns Hopkins University	Method and composition for the elimination of water from an animal body
CA1238577A (en) *	1983-05-24	1988-06-28	Gilbert V. Levin	Weight control drug
CA1324529C (en) *	1987-09-15	1993-11-23	Tatsuhiko Kan	Liquid food comprising polydextrose and oligosaccharides

1989
- 1989-10-17 US US07/422,694 patent/US5219573A/en not_active Expired - Lifetime
1990
- 1990-10-16 IE IE369990A patent/IE72475B1/en not_active IP Right Cessation
- 1990-10-16 AU AU64797/90A patent/AU640175B2/en not_active Expired
- 1990-10-16 IL IL9602090A patent/IL96020A/en not_active IP Right Cessation
- 1990-10-16 NZ NZ235698A patent/NZ235698A/en unknown
- 1990-10-17 AT AT90119935T patent/ATE107860T1/de not_active IP Right Cessation
- 1990-10-17 ES ES90119935T patent/ES2055270T3/es not_active Expired - Lifetime
- 1990-10-17 CA CA002027831A patent/CA2027831C/en not_active Expired - Lifetime
- 1990-10-17 NO NO90904495A patent/NO904495L/no unknown
- 1990-10-17 EP EP90119935A patent/EP0423771B1/de not_active Expired - Lifetime
- 1990-10-17 DE DE69010301T patent/DE69010301T2/de not_active Expired - Lifetime
- 1990-10-17 JP JP2278842A patent/JP3065648B2/ja not_active Expired - Fee Related
- 1990-10-17 ZA ZA908302A patent/ZA908302B/xx unknown

Also Published As

Publication number	Publication date
IE72475B1 (en)	1997-04-23
NO904495L (no)	1991-04-18
EP0423771B1 (de)	1994-06-29
AU640175B2 (en)	1993-08-19
CA2027831A1 (en)	1991-04-18
JP3065648B2 (ja)	2000-07-17
US5219573A (en)	1993-06-15
EP0423771A2 (de)	1991-04-24
DE69010301T2 (de)	1994-12-01
AU6479790A (en)	1991-04-26
CA2027831C (en)	2001-04-03
IL96020A0 (en)	1991-07-18
IE903699A1 (en)	1991-04-24
ZA908302B (en)	1991-08-28
JPH03223215A (ja)	1991-10-02
ES2055270T3 (es)	1994-08-16
NO904495D0 (no)	1990-10-17
NZ235698A (en)	1991-12-23
ATE107860T1 (de)	1994-07-15
DE69010301D1 (de)	1994-08-04
EP0423771A3 (en)	1991-11-27

Legal Events

Date	Code	Title
1997-01-10	KB	Patent renewed
2001-04-30	KB	Patent renewed
2005-02-20	KB	Patent renewed
2011-06-30	EXP	Patent expired

Publication	Publication Date	Title
US5219573A (en)	1993-06-15	L-sugar laxatives
Livesey	2001	Tolerance of low-digestible carbohydrates: a general view
AU2002364298B2 (en)	2009-01-15	Stimulation of the immune system with polydextrose
JPH07242539A (ja)	1995-09-19	緩下効果を有する組成物
EP1125507A1 (de)	2001-08-22	Inulinprodukte mit verbesserten Nahrungseigenschaften
US20030108594A1 (en)	2003-06-12	Food bars containing nutritional supplements
WO1993020718A1 (fr)	1993-10-28	Composition alimentaire inhibant la formation de produits de putrefaction intestinale
WO2013067424A1 (en)	2013-05-10	Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements
AU627431B2 (en)	1992-08-27	Psyllium-containing filling compositions and methods
US20080044493A1 (en)	2008-02-21	Agent For Ameliorating The Maximum Passage Time Through Digestive Tract, Agent For Ameliorating Passage Time Through Digestive Tract And Preventive For Colon Cancer
US7147883B1 (en)	2006-12-12	Compositions containing at least one polyol and inulin characterized by reduced tendencies of the at least one polyol to induce acute diarrhea
US5143728A (en)	1992-09-01	Psyllium-containing filling compositions and methods
HATA et al.	1991	Effects of soybean oligosaccharides on human digestive organs estimation of fifty percent effective dose and maximum non-effective dose based on diarrhea
CN106714582A (zh)	2017-05-24	慢消化性持续型能量补充剂
JPH05255097A (ja)	1993-10-05	液状組成物
US20100183774A1 (en)	2010-07-22	Glucosamine as a food and beverage additive
Abbott et al.	1958	Technical surgical factors which enhance or minimize postgastrectomy abnormalities
US4476121A (en)	1984-10-09	Bowel evacuant and method of treating constipation
US20070259094A1 (en)	2007-11-08	N-acetylglucosamine as a food and beverage additive
JP4601091B2 (ja)	2010-12-22	環状オリゴ糖
JPH09505824A (ja)	1997-06-10	便秘の治療におけるジメチコーンの使用
US5500190A (en)	1996-03-19	Anion exchange resin compositions containing almond paste for taste improvement
KR100221396B1 (ko)	1999-09-15	미감이 개선된, 질경이와 콜레스티라민의 조성물
Brucker	1988	Management of common minor discomforts in pregnancy: Part III: Managing gastrointestinal problems in pregnancy
JPS60112720A (ja)	1985-06-19	肝臓疾患治療効果を有する薬剤